Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Company News
Events
Directory
Search
Close search
Home
Company
Open Book Extracts
Open Book Extracts
Activities:
Ingredients
X
LinkedIn
Trending Articles
DolCas Biotech exhibits novel curcumin chocolate at Vitafoods Europe
Curcugen, the curcumin-infused dark chocolate, can offer support in gut health and mood management
ADM exceeds 2m acre regenerative agriculture goal for 2023
Launch of regenerative agriculture initiatives in Europe, Latin America accelerate global progress as company works toward 3.5 million acres in 2024
Epax slashes carbon emissions in its transition to renewables
The company is now powered by 100% renewable energy and has reduced its emissions by 22.3% in the last 4 years
Sygnature Discovery receives Ecovadis award for sustainable excellence
The award recognises the company's efforts to enhance its social and ethical performance with high standards
Sirio launch PureOrganix range of gummies and softgels at Vitafoods Europe
The new market-ready organic range includes top-trending ingredients, including EPO, flaxseed oil and apple cider vinegar
Upcoming event
Vitafoods Europe
14–16 May 2024 | Exhibition | Palexpo, Geneva
See all
Related Content
Ingredients
Open Book Extracts (OBX) announces founding membership in ONE HEMP
Since the inception of Open Book Extracts (OBX) in 2019, the company has served as a leader in the hemp-based CBD market, prioritising science, safety, and responsible commerce
Ingredients
OBX launches trial for minor cannabinoid formulations
The cannabinoids selected were CBD, CBG, CBC, and CBDV, and the polyphenols selected were Quercetin and Curcumin
Finance
OBX receives strategic investment from Btomorrow Ventures
The two companies have signed a scientific collaboration agreement covering areas of future R&D
Ingredients
Open Book Extracts expands capabilities and management team to boost finished goods manufacturing
The expansion will serve to address increased demand for the company’s product development and manufacturing services
Regulatory
OBX announces results of Phase I toxicology assessment
The company contracted AIBMR Life Sciences to conduct the studies investigating the safety of consuming its CBG, CBN, and CBC products
Ingredients
OBX completes trial of cannabinoids for pain relief
Results from the pain study are expected in late April 2022 and will be announced at that time
Ingredients
Open Book Extracts appoints European sales leadership
In March 2021, OBX became a member of the European Industrial Hemp Association Novel Food Consortium
Subscribe now